The Cabot Value Model stocks have outperformed the stock market by a wide margin in 2016, and I expect that outperformance to continue for the remainder of the year. This month, I’m adding Cognizant Technology (CTSH) and Zimmer Biomet Holdings (ZBH) to the Cabot Value Model; I expect Cognizant and Zimmer to add growth potential without additional risk.
